South Africa Newborn Screening Market Size & Outlook

The newborn screening market in South Africa is expected to reach a projected revenue of US$ 39.7 million by 2030. A compound annual growth rate of 8% is expected of South Africa newborn screening market from 2024 to 2030.
Revenue, 2023 (US$M)
$23.1
Forecast, 2030 (US$M)
$39.7
CAGR, 2024 - 2030
8%
Report Coverage
South Africa

South Africa newborn screening market highlights

  • The South Africa newborn screening market generated a revenue of USD 23.1 million in 2023 and is expected to reach USD 39.7 million by 2030.
  • The South Africa market is expected to grow at a CAGR of 8% from 2024 to 2030.
  • In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
  • Tandem Mass Spectrometry is the most lucrative technology segment registering the fastest growth during the forecast period.


Newborn screening market data book summary

Market revenue in 2023USD 23.1 million
Market revenue in 2030USD 39.7 million
Growth rate8% (CAGR from 2023 to 2030)
Largest segmentTandem mass spectrometry
Fastest growing segmentTandem Mass Spectrometry
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis
Key market players worldwideBio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp


Other key industry trends

  • In terms of revenue, South Africa accounted for 2.9% of the global newborn screening market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia newborn screening market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 33.1 million by 2030.

Tandem mass spectrometry was the largest segment with a revenue share of 24.68% in 2023. Horizon Databook has segmented the South Africa newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.


According to a study published in South African Medical Journal, permanent hearing impairment is reviewed in over 180,000 babies with about 17 being born each day. To accurately diagnose the presence of this disorder, the public health sector has set up the Early Hearing Detection and Intervention (EHDI) program.

Reason for low implementation of screening was concluded to be due to three factors. These include non inclusion of the screening procedure in maternity birthing package, lack of cost coverage by Medical Aid Scheme, and poor follow-up by the parents. An effort towards eradication of these challenges over the forecast period is expected to make South Africa a lucrative market for the industry.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Newborn Screening Market Companies

Name Profile # Employees HQ Website

South Africa newborn screening market size, by technology, 2018-2030 (US$M)

South Africa Newborn Screening Market Outlook Share, 2023 & 2030 (US$M)

South Africa newborn screening market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more